[Antipsychotic-induced weight gain--pharmacogenetic studies].
Drug-naive patients with schizophrenia often present metabolic abnormalities and obesity. Weight gain may be the side effect of treatment with many antipsychotic drugs. Genetic effects, besides many other factors, are known to influence obesity in patients with schizophrenia treated with antipsychot...
Main Authors: | Olajossy-Hilkesberger, L, Godlewska, B, Marmurowska-Michałowskal, H, Olajossy, M, Landowski, J |
---|---|
Format: | Journal article |
Language: | Polish |
Published: |
2006
|
Similar Items
-
Antipsychotic-induced weight gain - Pharmacogenetic studies
by: Olajossy-Hilkesberger, L, et al.
Published: (2006) -
[Atypical antipsychotic-induced weight gain].
by: Godlewska, B, et al.
Published: (2006) -
Atypical antipsychotic-induced weight gain
by: Godlewska, B, et al.
Published: (2006) -
Polymorphisms of the histamine receptor (H1HR) gene are not associated with olanzapine-induced weight gain.
by: Godlewska, B, et al.
Published: (2013) -
Olanzapine-induced weight gain is associated with the -759C/T and -697G/C polymorphisms of the HTR2C gene.
by: Godlewska, B, et al.
Published: (2009)